HDFC Securities recommends 'Add' rating for LIC, Aurobindo Pharma, Star Cement, Metropolis, Godrej Properties, Birlasoft, 'Buy' Symphony, Crompton, Astral, 'Reduce' Alkyl Amines, Clean Science

(Image Source: Canva AI) LIC printed a beat on APE growth (+3% YoY), led by group business growth (+20% YoY). Mankind Pharma's Ebitda (+8% YoY) was 6% below estimates as 20% YoY sales growth (India formulation up 15% YoY and exports +14%) was offset by muted gross margin (-29 bps) and higher staff and SG&A costs, resulting in 24.9% margin (-271 bps). Aurobindo Pharma's Ebitda grew 7% YoY, aligning with consensus estimates.

To continue reading this story You must be an existing Premium User Already a Premium User? Sign In

See Full Page